Onderneming Nuvo Pharmaceuticals Inc.
Aandelen
MRV
CA67092F1045
Farmaceutische producten
Vakgebied
Aantal werknemers: 101
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jesse Ledger
CEO | Chief Executive Officer | - | 06-04-16 |
Director of Finance/CFO | - | 01-01-12 | |
Bernard Chiasson
COO | Chief Operating Officer | - | - |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | - |
John London
BRD | Director/Board Member | - | - |
Corporate Officer/Principal | - | 01-01-19 | |
Cally Lunetta
PRN | Corporate Officer/Principal | - | - |
Katina Loucaides
LAW | General Counsel | - | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rob Harris
CHM | Chairman | 69 | 05-04-17 |
Director/Board Member | - | 21-09-04 | |
John London
BRD | Director/Board Member | - | - |
Mary Ritchie
BRD | Director/Board Member | 67 | 17-05-21 |
Anthony Y. Snow
BRD | Director/Board Member | 49 | 12-08-22 |
Director/Board Member | 68 | 16-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 388 000 | 10 851 712 ( 95,29 %) | 0 | 95,29 % |
Bedrijfsgegevens
Nuvo Pharmaceuticals, Inc.
6733 Mississauga Road Suite 800
L5N 6J5, Mississauga
+
http://www.miravohealthcare.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |